Related posts

Most Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Imaflex Inc. (IFX-X) has experienced a decline in revenues, with net debt rising and cash declining. Cash flow and operations have been positive overall, but turned negative in Q2. Net income also saw a significant year-over-year decline. The share price is down, but valuation remains cheap. The company faces challenges attributed to small-cap pressures, economic headwinds, customer destocking, and a competitive pricing environment. Management remains optimistic for the second half of the year, but future outlook is uncertain. Overall, IFX-X is considered risky for general investors.

Consensus
uncertain
Valuation
Undervalued
DON'T BUY
Imaflex Inc.
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

IFX has seen revenues decline over the last 12 months, down -18.8% to $96.1M. The balance sheet is not as strong as earlier in the year with net debt rising to $7M and cash declining from prior periods to $3M. Cash from operations as well as free cash flow are positive in the last twelve months, however, in Q2 both of these came in negative. Net income in Q2 came in a bit above $400K which was a significant year-over-year decline from $3.4M. IFX's share price is down -33% year-to-date but still has a cheap valuation at 12x forward earnings. IFX is facing a slowdown due to small-cap pressures and management has tied the weak first half of 2023 to economic headwinds, customer destocking, and a competitive pricing environment. Management remains optimistic for the second half of the year, but being such a small company, future outlook is uncertain. It has one analyst, who does expect higher earnings next year. But we would consider it too risky for a general investor.
Unlock Premium - Try 5i Free 

packaging / containers
COMMENT
Imaflex Inc.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues grew from $21M in 2020 to $24.9M in 2021. Net income decreased, though it is largely attributed to foreign exchange negatively affecting the company. Operating expenses are being kept under control. The company still looks cheap on all metrics. Continues to perform well and deliver results. Unlock Premium - Try 5i Free

packaging / containers
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Imaflex Inc.(IFX-X) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Imaflex Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Imaflex Inc.(IFX-X) Frequently Asked Questions

What is Imaflex Inc. stock symbol?

Imaflex Inc. is a Canadian stock, trading under the symbol IFX-X on the TSX Venture Exchange (IFX-CV). It is usually referred to as TSXV:IFX or IFX-X

Is Imaflex Inc. a buy or a sell?

In the last year, 1 stock analyst published opinions about IFX-X. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Imaflex Inc..

Is Imaflex Inc. a good investment or a top pick?

Imaflex Inc. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Imaflex Inc..

Why is Imaflex Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Imaflex Inc. worth watching?

In the last year, there was no coverage of Imaflex Inc. published on Stockchase.

What is Imaflex Inc. stock price?

On 2024-02-27, Imaflex Inc. (IFX-X) stock closed at a price of $0.81.